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Summary
What is already known on this topic?
Partnering across organizational boundaries is critical to accountable care
organization (ACO) success.
What is added by this report?
We explored how Oregon’s Medicaid ACOs are working with primary care
clinics to improve the colorectal cancer (CRC) screening performance met-
ric. We identified partnership, performance data, and quality improvement
infrastructure as critical dimensions when ACOs and primary care clinics
work to implement interventions to improve CRC screening. Unintended
consequences included the potential exclusion of smaller clinics and met-
ric focus and fatigue.
What are the implications for public health practice?
Practitioners looking to build cross-sector ACO–clinic partnerships to in-
crease CRC screening or address other performance metrics should con-
sider these 3 key collaborative factors and 2 unintended consequences.
Abstract
Purpose
Accountable Care Organizations (ACOs) are implementing inter-
ventions to achieve triple-aim objectives of improved quality and
experience of care while maintaining costs. Partnering across or-
ganizational boundaries is perceived as critical to ACO success.
Methods
We conducted a comparative case study of 14 Medicaid ACOs in
Oregon and their contracted primary care clinics using public per-
formance data, key informant interviews, and consultation field
notes. We focused on how ACOs work with clinics to improve
colorectal cancer (CRC) screening — one incentivized perform-
ance metric.
Results
ACOs implemented a broad spectrum of multi-component inter-
ventions designed to increase CRC screening. The most common
interventions  focused  on  reducing  structural  barriers  (n  =  12
ACOs), delivering provider assessment and feedback (n = 11), and
providing patient reminders (n = 7). ACOs developed their pro-
cesses and infrastructure for working with clinics over time. Facil-
itators of successful collaboration included a history of and com-
mitment to collaboration (partnership); the ability to provide ac-
curate data to prioritize action and monitor improvement (perform-
ance data), and supporting clinics’ reflective learning through fa-
cilitation, learning collaboratives; and support of ACO as well as
clinic-based staffing (quality improvement infrastructure). Two
unintended consequences of ACO–clinic partnership emerged: po-
tential exclusion of smaller clinics and metric focus and fatigue.
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Conclusion
Our findings identified partnership, performance data, and quality
improvement infrastructure as critical dimensions when Medicaid
ACOs work with primary care to improve CRC screening. Find-
ings may extend to other metric targets.
Introduction
Federal and state policies in the United States are increasingly
moving away from pay for performance and toward reimburse-
ment models that support the triple-aim objectives of improved
quality and experience of care for populations while controlling
costs (1). The Affordable Care Act, which was passed in March
2010,  has many provisions that  encourage achievement of  the
triple aim through expanded access to preventive care services, in-
cluding encouraging cross-sector collaborations for care delivery
through accountable care organizations (ACOs). ACOs are ac-
countable for the quality and total costs of care for a defined popu-
lation.
ACOs began in Medicare as a way to deliver high-quality, co-
ordinated care; states have also expanded this model to Medicaid
(2,3).  Increased coordination and accountability in ACOs may
lead to wiser spending and improved quality of care by delivering
the right care to the right patient at the right time. In such cases,
shared savings may be distributed across partner agencies (2).
However, early research suggests there is considerable variation in
partnership structures, decision making, and reimbursement mod-
els for ACOs (4,5). Moreover, the interventions that ACOs pursue
and how they implement them may vary drastically and have im-
plications for program effectiveness. Research suggests that ACO
success will hinge on the ability of health care organizations to
successfully partner across boundaries (6).
One quality indicator across many ACO and payer initiatives is
colorectal cancer (CRC) screening (7,8). CRC is the second lead-
ing  cause  of  cancer  deaths  in  the  United  States,  causing  over
50,000 deaths annually (9). Guideline-concordant screening using
endoscopic or fecal testing options can reduce CRC morbidity and
mortality rates and is cost-effective (10,11). However, little re-
search explores what interventions ACOs implement to increase
CRC screening or how they work with primary care clinics.
Therefore, we sought to understand how ACOs work with primary
care clinics to improve CRC screening. We focused on Oregon be-
cause of the opportunity to analyze 16 Medicaid ACOs (called co-
ordinated care organizations or “CCOs”) to understand 1) which
types of interventions CCOs are using to improve CRC screening
rates and 2) how CCOs work with primary care clinics to imple-
ment the target interventions. Our study was designed to be hypo-
thesis generating and to suggest promising practices to facilitate
effective ACO–clinic partnerships to achieve performance bench-
marks for CRC screening.
Methods
In 2011 the Oregon legislature passed House Bill 3650, authoriz-
ing the formation of CCOs. By statute, CCOs are governed by a
partnership between those taking financial risk, professionals in
the local health system (eg, doctors, hospitals), and community
members; no CCO directly owns primary care clinics (12). CRC
screening has been a CCO quality incentive metric since program
inception, with annual reporting initiated in 2013.
We conducted a cross-case comparative study of CCOs in Oregon
by using public performance data, transcripts from key informant
interviews, and field notes from technical assistance consultations
with CCO leadership.  Our  study was conducted in  2016,  four
years after CCO formation began. The institutional review board
at Oregon Health and Science University approved this study (no.
11454).
Data collection and participant sampling
First, we collected publicly reported data about CCO characterist-
ics and CRC screening performance in early 2016; we added 2016
CRC screening rates when they became available in 2017. Second,
2 members  of  the  study team (M.M.D.,  R.P.)  conducted CRC
technical assistance consultation meetings with CCO leadership
and quality improvement teams during June and July of 2016. Fi-
nally, one member of the study team (M.M.D.) conducted key in-
formant interviews with a purposive sample of stakeholders from
CCOs, primary care clinics,  and the state from February 2016
through August 2016. Interviews followed a semistructured guide
designed to clarify our understanding of how CCOs worked with
clinics to address the CRC incentive metric. Interviews lasted ap-
proximately 60 minutes (range, 31–118 min) and were audio re-
corded and professionally transcribed.
Data management and analysis
Interview transcripts were checked for accuracy, and data were de-
identified and analyzed using Atlas.ti version 7.0 (Atlas.ti Scientif-
ic Software). We found that existing conceptual frameworks and
models did not account for the developmental nature of ACO and
clinic partnerships over time (13). Therefore, we analyzed our data
inductively to allow key themes to emerge naturally from the data.
We collected and analyzed data concurrently until saturation was
reached (14). We used an iterative approach informed by Crabtree
and Miller’s 5-stage immersion-crystallization analysis process
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(15).  First,  2  authors (M.M.D.,  R.P.)  reviewed transcripts  and
coded key segments of text with descriptive names (eg, partner-
ship development,  intervention targets)  using a group process.
Second, we reviewed data from a single CCO to understand how
the organization was approaching CRC screening improvement
and how they engaged primary care clinics and other stakeholders
in this work. In a third cycle, 3 authors (M.M.D., R.P., R.G.) con-
ducted a cross-case comparative analysis to identify patterns in
CCO–clinic partnerships and associated performance on the CRC
screening metric.  We refined emerging themes with the larger
study team and shared preliminary findings with OHA staff as a
form of member checking (16). Use of reflexivity, multiple re-
viewers, data saturation, and an audit trail are associated with rig-
or in qualitative research methods (14,17).
Results
In 2015 the 16 CCOs ranged in size from 11,347 to 228,263 Medi-
caid enrollees and had an average CRC screening rate of 46.4%
(Table 1). Qualitative data were gathered from 14 CCOs (88% re-
sponse rate). Thirty-eight informants representing 10 CCOs parti-
cipated in technical assistance consultations; 26 stakeholders rep-
resenting 12 CCOs participated in key informant interviews. Inter-
view participants represented CCO leadership (n = 16), primary
care clinics (n = 6), and the state (n = 4).
Participating CCOs were actively implementing multiple interven-
tion strategies, including those to increase community demand, in-
crease community access, and increase provider delivery of CRC
(Table 2). The most common intervention strategies were redu-
cing structural barriers (85.7%, n = 12), delivering provider as-
sessment and feedback (78.6%, n = 11), and offering patient re-
minders (50.0%, n = 7). All 14 CCOs implemented intervention
strategies with sufficient evidence of effectiveness according to
the Community Guide (www.thecommunityguide.org); more than
half (n = 8) were also implementing interventions with insuffi-
cient evidence.
CCOs addressed 3 key areas when working with primary care
clinics to improve CRC screening: 1) establishing relationships
and building partnerships, 2) producing and sharing performance
data, and 3) developing a process and infrastructure to support
quality improvement (Figure). Illustrative quotes detailing these
themes are in Table 3.
Figure.  Three  key  collaborative  factors  when Medicaid  accountable  care
organizations work with primary care clinics to achieve performance metrics
for CRC screening. Abbreviations: CRC, colorectal cancer; CCO, coordinated
care organization.
Establishing relationships and building partnerships
Relationships played an important role in shaping how CCOs in-
teracted with primary care clinics in their service region and in
their ability to make improvements. Relationship quality could fa-
cilitate as well as impede the selection and implementation of in-
terventions to increase CRC screening.
Prior history between CCO leadership and primary care stakehold-
ers, physical proximity of the CCO’s infrastructure, and joint lead-
ership roles in the CCO and regional clinics shaped the tenor of
these relationships. One stakeholder noted, “We really just try to
build the bond and leverage our existing relationships. . . . We had
an advantage to be able to walk into the clinics and have a pretty
long history of trust” (Participant 18). In contrast, CCOs that built
on less-developed partnerships, strained relationships, or those that
lacked a physical presence in the community faced challenges in
raising local awareness and building trust.
CCOs developed or built on their relationships and partnerships
with primary care clinics over time in 4 key ways. First, they had
primary care providers and clinic leadership serve on the CCO
board or on various subcommittees. Second, they hired local staff
to provide ongoing support and to facilitate change in the primary
care clinics. Third, CCO staff spent time listening, building trust,
and aligning CCO initiatives with health system–level and clinic-
level priorities and needs. Finally, CCOs created or expanded per-
manent physical space to house their staff in the local communit-
ies served.
Producing and sharing performance data
Performance data provided a starting point to prioritize and direct
improvement activities for the CCOs and their contracted primary
care clinics. CCOs used CRC screening data to inform targeted
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clinic outreach; motivate improvement at the clinic, provider, and
team levels; and monitor progress toward performance goals. A
first step was to obtain and share accurate performance data with
clinics. One CCO medical director commented, “I think everyone
assumes they’re doing a good job, until we can present them with
credible evidence otherwise” (Participant 14). Some CCOs with-
held incentive metric resources in early years to “put a system to-
gether to provide data to our partners so that they could do that im-
provement work on accurate, reliable data” (Participant 25).
CCO leadership anticipated that routinely sharing performance
data  and  gap  lists  for  CRC screening  would  enable  clinics  to
“scrub their schedules as people are coming in or be reaching out
to patients [using a population management approach]” (Parti-
cipant 16). Over time, CCOs learned to be more strategic in how
they distributed the gap lists for CRC screening — in terms of
who at the clinic received them and how the data were presented
and/or accessed — and they created processes to increase data ac-
curacy by enabling clinics to amend CCO claims data with histor-
ical screening recorders. Low-quality, inaccurate data were poorly
received by clinic partners. One clinic member said, “We would
get reams of paper, and about the fourth or fifth page in when
three-quarters [of the patients] . . . weren't assigned to us we saw
them as un-useful and put them aside” (Participant 8).
CCOs that had good standing relationships with clinics and the
ability to generate metric data could also promote friendly, pro-
ductive competition with transparent reporting of metric perform-
ance data, as illustrated in the following quote:
[Routine sharing of identified performance data] has generated
competition, transparency, and a spirit of collaboration. Clinics can
look at each other and say, “Boy, you're doing great. Tell me what
your secret is and let's figure this out together, and will you help
us? What did you do to get from here to here?” (Participant 12)
However, clinics varied in their ability to respond to performance
data. Some clinics distributed performance data to panel managers
who would then reach out to patients. Without dedicated staff to
process or act on the CCO reports, the data languished at a clinic.
Developing a process and infrastructure to support
quality improvement
Relationships and data allowed CCOs to partner with clinics and
health system leadership to focus on quality improvement initiat-
ives at the clinic level. CCO-funded regionally based improve-
ment staff focused on building relationships and supporting clin-
ics as they worked to achieve the incentive metrics,  including
CRC screening. One CCO improvement facilitator described how
the metrics were straightforward to understand, but the approach
to achieve these metrics at each clinic required targeted support.
Facilitators described asking, “What does it take for this clinic to
implement this?” (Participant 4), then building a tailored improve-
ment approach that attended to clinic needs (eg, addressing leader-
ship, understanding and using data, improving team functioning).
Improvement facilitators often began by educating providers on
the quality metrics then helping clinics refine clinical workflows
or implement strategies to improve service delivery frequency.
Some CCOs also led regional learning collaboratives and funded
clinic-based quality improvement staff. Learning collaboratives al-
lowed quality improvement leads and staff from regional clinics to
gather and share best practices, troubleshoot workflows, and plan
their  own  initiatives.  Clinic-based  quality  improvement  staff
helped lead clinic change or were panel managers who performed
key tasks to support improvement efforts for CRC screening and
other incentive metrics.
Promising practices
Despite heterogeneity in interventions implemented across CCOs,
certain patterns stood out as promising in relation to CCO–clinic
partnerships to improve CRC screening. Stakeholders noted how
certain CCOs leveraged their relationships with partner clinics or
funded staff to help implement changes in care delivery needed to
achieve CRC screening metric benchmarks. The ability to provide
accurate data to prioritize action and improvement monitoring was
also critical. However, clinics also needed a process for acting on
this information. Although some clinics had robust quality im-
provement infrastructure, others needed resources and training to
be  able  to  review  data,  select  interventions,  and  implement
changes. In contrast, some CCOs with lower levels of clinic en-
gagement and data reporting or  sharing capacity implemented
CRC initiatives that circumvented clinics (eg, offering fecal tests
for  CRC screening  directly  to  Medicaid  enrollees).  Although
CCO-led interventions could increase CRC screening rates, in-
formants indicated that this approach contributed to over-screen-
ing by duplicating clinic-level workflows, raised concerns about
legal ramifications in relation to patient follow-up on abnormal
results, and reduced the willingness of clinics and health systems
to collaborate.
Unintended consequences
Collaboration between CCOs and clinics suggested 2 emerging
and unintended consequences: 1) prioritizing larger clinics and ex-
cluding smaller clinics and 2) metric focus and fatigue. The abil-
ity to generate high-quality data and the need to build relation-
ships and quality improvement infrastructure led many CCOs to
focus their attention and resources on larger clinics. Stakeholders
expressed concern that some of the smaller clinics — which may
have more limited quality improvement capacity to begin with and
PREVENTING CHRONIC DISEASE VOLUME 16, E107
PUBLIC HEALTH RESEARCH, PRACTICE, AND POLICY       AUGUST 2019
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services,
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.
4       Centers for Disease Control and Prevention  •  www.cdc.gov/pcd/issues/2019/18_0395.htm
are often found in rural areas where screening disparities exist —
were not given data reports from the CCO or support with im-
provement. One stakeholder commented, “Sadly, I think if you
look at the large clinics that are doing well . . . we consider[ed]
that a win and we move[d] on. I would hate for someone to not be
screened [for CRC] just because of the clinic they chose” (parti-
cipant 22).
A second unintended consequence was a focus on the CCO met-
rics to the exclusion of other factors associated with quality of care
and feelings of metric fatigue. Stakeholders commented on the
number of metrics that clinics are responsible for, the burden of
capturing and reporting data, and the pressure for continual im-
provement. “People are just exhausted. They come to the end of a
metric year and . . . it's like fighting with every ounce of energy
you have to make sure that you’ve got enough people under your
belt to hit a particular metric” (participant 12).
Discussion
Our study explored how Medicaid ACOs (CCOs in Oregon) work
with primary care clinics to improve CRC screening. CCOs ad-
dressed 3 key collaborative factors: establishing relationships and
building partnerships, producing and sharing performance data,
and developing quality improvement processes and infrastructure.
All  CCOs were  implementing  multi-component  interventions,
some with sufficient evidence and others with insufficient evid-
ence of effectiveness. Access to and knowledge of the perform-
ance metrics and an expectation that clinics would take action to
increase CRC screening improvement was necessary but not suffi-
cient. Robust relationships, high-quality actionable data, and help-
ing clinics fund and figure out how to make improvements are
promising practices associated with enhanced CCO–clinic collab-
oration to increase CRC screening.
Two unintended  consequences  emerged  in  our  exploration  of
CCO–clinic partnerships that warrant additional attention. First,
neglect or exclusion of smaller clinics may increase CRC screen-
ing disparities, and smaller clinics may experience more barriers to
implementing change (18–20). Including smaller clinics is critical
in supporting improved care, given that 78% of patients in the
United States still receive care in clinics with 10 or fewer physi-
cians (21). Second, metric focus and fatigue suggests the need to
attend proactively to provider and staff burnout, to support team-
based care models, and to stay cognizant of what “gets missed” as
ACOs and CCOs focus on quality metrics at the potential expense
of quality (22).
Our study contributes to a growing body of literature on effective
practices for ACOs and to the broader literature on cross-sector
partnerships and multi-level interventions using CRC as a case
study. Findings encourage use of participatory approaches that at-
tend to local context and needs (23,24) and support improvement
as a dynamic process within a complex system using a “best pro-
cesses” orientation (25).
Two areas warrant additional consideration. First, our findings
highlight the opportunities and challenges of building cross-sector
partnerships to implement interventions that increase CRC screen-
ing. Stakeholders described the importance of building trusting re-
lationships and basic infrastructure as part of efforts to implement
evidence-based interventions in routine care. Although ACOs may
want to focus on specific interventions first, building basic im-
provement capacity can lay the foundation for successful imple-
mentation later. Second, although selecting an evidence-based in-
tervention is a key component of improvement practice, determin-
ing how to support implementation is a critical determinant of in-
tervention success. Facilitation — or providing support to aid im-
plementation — is increasingly recognized as a critical factor of
implementation success (26,27). Facilitators may engage key part-
ners to implement needed change, to create a safe space for data
sharing and reflection on improvement targets, and to optimize in-
tervention delivery and understanding over time (28,29). Finally,
our study findings suggest that in certain cases ACOs may also
need to provide internal staffing support to enable clinics to imple-
ment interventions to achieve performance benchmarks. Even if
well-intentioned, providing technical support without considering
how to resource or to reward clinics and staff for making change
may be poorly received and lack anticipated impact (30).
Our study has limitations. First, our data were cross-sectional. Al-
though stakeholders described how CCOs were evolving their
strategies over time, we were not able to evaluate these changes in
detail or to definitively identify successful and unsuccessful inter-
vention or implementation strategies. Future studies would benefit
from assessing changes in CCO approaches over time, and their
association with performance metrics. Also, we focused on how
CCOs  worked  with  primary  care  clinics  on  one  metric,  CRC
screening. It is possible that different metrics may require other
strategies to address. Regardless, our findings are likely generaliz-
able to other preventive screenings.
Partnerships are perceived as critical to ACO success. We found
that Oregon Medicaid ACOs engaged with primary care clinics to
improve CRC screening by implementing multi-component inter-
ventions (eg, reducing structural barriers, delivering provider as-
sessment and feedback, providing patient reminders). Facilitators
of successful collaboration included a history of and a commit-
ment to collaboration, the ability to provide accurate data to prior-
itize action and monitor improvement, and supporting clinics’ re-
flective learning through facilitation, learning collaboratives, and
support of clinic-based staff. Perceived exclusion of smaller clin-
PREVENTING CHRONIC DISEASE VOLUME 16, E107
PUBLIC HEALTH RESEARCH, PRACTICE, AND POLICY       AUGUST 2019
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services,
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.
www.cdc.gov/pcd/issues/2019/18_0395.htm • Centers for Disease Control and Prevention       5
ics  and  metric  focus  and  fatigue  emerged  as  unintended  con-
sequences of these improvement efforts and warrant additional at-
tention. ACO–clinic partnerships must go beyond simply sharing
what is needed for improvement to helping clinics figure out how
to make improvements, which may include resourcing external
and internal infrastructure. Our findings can inform ACOs how to
effectively  partner  with  primary care  clinics  to  improve CRC
screening and may extend to other performance metrics.
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Tables
Table 1. Characteristics of Oregon’s Medicaid Accountable Care Organizations,a Public Data 2015
Organization Name Structure
Nonprofit
Status
Number of
Enrollees
Enrollee composition
% White % Hispanic
% African
American
% With a
Disability
AllCare Health Plan Corporation No 48,790 71.7 10.5 0.9 6.5
Cascade Health Alliance LLC No 16,439 65.7 15.2 1.4 8.0
Columbia Pacific LLC Yes 24,975 72.7 9.6 0.7 6.3
Eastern Oregon LLC No 47,651 58.7 24.2 0.8 6.3
FamilyCare Corporation Yes 123,084 51.1 15.9 5.7 2.8
Health Share of Oregon Corporation Yes 228,263 49.9 18.0 7.8 8.5
Intercommunity Health Network Corporation Yes 54,679 69.4 10.7 0.8 7.8
Jackson Care Connect LLC Yes 29,157 64.5 15.8 0.9 6.1
PacificSource–Central Oregon Corporation Yes 51,973 70.6 12.2 0.6 5.5
PacificSource–Gorge Corporation Yes 12,833 52.3 33.3 0.6 4.8
PrimaryHealth of Josephine County LLC Yes 11,347 73.9 7.9 0.6 6.7
Trilliumb Corporation No 90,564 70.1 9.8 1.8 8.3
Umpqua Health Allianceb LLC No 26,203 79.4 6.2 0.5 8.6
Western Oregon Advanced Health LLC No 20,048 77.3 7.4 0.6 9.9
Willamette Valley Community Health LLC No 98,112 51.5 28.5 1.4 6.6
Yamhill Community Care Corporation Yes 22,466 62.4 20.7 0.7 4.0
Abbreviation: LLC, limited liability corporation.
a Also known as coordinated care organizations (CCOs).
b Not included in subsequent analyses due to lack of qualitative data. Of the 16 CCOs, 14 participated in either the CCO technical assistance consultation or key in-
formant interviews or both.
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Table 2. Interventions Being Implemented by Oregon CCOs, Reported in 2016 (N = 14)a
CCO IDb
Increase Community Demand
Increase
Community
Accessd Increase Provider Delivery CRC Screening Rate
Patient
Remindersc
Patient
Incentives
Small
Mediac
Mass
Media
One-on-One
Educationc
Reducing
Structural
Barriersc
Provider
Assessment
and
Feedbackc
Provider
Reminder
and Recallc
Provider
Incentives 2014 2015 2016
A X X X X X 53.3 51.7 52.8
B X X 47.4 48.8 52.6
C X X X 47.0 47.8 48.5
E X X 46.7 47.3 51.1
F X X X 48.4 49.9 55.0
G X X X 46.7 49.4 49.9
H X X X X 54.0 43.8 51.8
I X X X X X X 35.3 36.0 40.9
J X X X X X X 29.7 38.7 43.1
K X X X X X 31.6 46.6 47.9
M X X X 53.5 49.0 50.6
N X X 51.8 49.1 54.5
O X X X X 52.1 47.7 47.4
P X X X X X 40.5 44.3 53.5
Abbreviations: CCO, coordinated care organization; CRC, colorectal cancer; ID, identification.
a The interventions identified are provided by and defined from the Community Guide (www.communityguide.org).
b Qualitative data was not available for CCOs D or L.
c Intervention with sufficient evidence of effectiveness.
d Reducing patient out-of-pocket costs (an intervention with insufficient evidence of effectiveness) does not appear in the table because it did not emerge as an in-
tervention being implemented by any CCO.
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Table 3. Illustrative Quotes for Key Themes and Unintended Consequences
Theme Illustrative Quotes
Key factors in CCO–clinic collaborations
Establishing relationships and
building partnerships
[CCO Name] is cited as a real pioneer in this work. . . . They have had such incredible community investment from the very
beginning. It's not like they have to talk their partners into doing something or engaging in work around the metrics . . .
because the partners were there from the beginning and were part of the founding governing board. (P12)
We were really close with some clinics, and they trusted us. And some clinics, we didn’t have as close a relationship. So we
had to figure that out in the strategy. [Now our relationships are] pretty close . . . partially because there’s a lot of need and
they realize that we want to help. We don’t have some crazy ulterior motive. Our motive is the same as theirs. We want
access for patients and quality care. (P7)
Producing and sharing performance
data
We’ve gotten more sophisticated about [our process of sharing performance data]. . . . We identified somebody at the clinic
that’s our contact. It may be administration or care management, it’s not necessarily going to be the primary care provider
anymore. (P10)
This CCO puts [performance data] in front of all of the providers on a regular basis. This is how you’re doing, this is how the
clinic next to you is doing, this is how the clinic down the street is doing. I would have thought that would have been very
risky, but . . . [it] has generated competition and it's generated transparency and it’s generated a spirit of collaboration
because clinics can look at each other and say, “Boy, you’re doing great. Tell me what your secret is and let’s figure this out
together, and will you help us? What did you do to get from here to here?” (P12)
Developing a process and
infrastructure to support quality
improvement
[We consider] each clinic and say, “For this clinic, what is it for them?” They’ve already got strong leadership, so maybe for
them it’s that their data system makes it really difficult for them to track this metric. . . . We try to personalize our knowledge
of each clinic to ensure that when we take something that seems straightforward, like they just need to improve the
numerator hits for this process and it seems straightforward because you should just send out kits and they should get sent
back but there’s always more beneath the surface. And typically what’s underneath it is some kind of system support that is
not in place. (P4)
Our first step is usually to educate the providers and their staff on what the quality measures are, how they are tracked, what
kind of data are OHA looking for and what documentation do they need and the clinical record to back up that information . . .
and then looking at what kind of clinical workflows or other strategies we can suggest to them or help them with that would
improve the actual frequency in which services are occurring. (P16)
It’s those kinds of hard stories that the clinics aren’t afraid to share [at the learning collaboratives] once we’ve developed
trust . . . where they feel comfortable sharing their failures with each other, so you’re not [going] down the street reinventing
the same crooked wheel. (P3)
Unintended consequences
Engaging larger clinics, exclusion of
smaller clinics
I feel for [these small clinics], because I think they're at a disadvantage in that larger clinics have built-in infrastructure of IT
people, of performance improvement people, 3-tier leadership. . . . In some clinics, the office manager is the billing manager,
is the front desk manager, is everything. I worry about those clinics and I wonder how they are doing. I don’t know if that falls
on the CCO to provide that sort of infrastructure. Maybe it does. I just worry that they're being overlooked. (P22)
We have really good reporting. . . . We have gap lists that we can produce by clinic, by provider, by measure. We know who’s
got the most members for that measure, who’s contributing the most to the numerator and to the denominator so that we
know where to target. Usually you would just go, “Oh, let’s let everybody know that we don’t, or everybody has to have them.”
Well, now we go, “Okay, if we approach this one clinic, we can get everything we need to make the measure.” . . . We’re just
being very strategic about that. (P10)
Metric focus and fatigue
For good or for bad, I think the metrics are really driving a lot of the effort now, and if there’s any bandwidth leftover after
you’ve hit the metrics, then they focus on those things that don’t necessarily impact the check at the end of the year. . . .
Somebody said just a couple of weeks ago, “I thought this would get easier. I thought it would calm down. I thought it would
become more routine functioning, and it isn’t.” It is intense work, and it has been from the beginning. (P12)
That’s probably the biggest thing that hit the clinics with new metrics, which is one more thing. “We just are barely getting this
other thing working, and now you want us to do one more, you want us to do 2 more, and 3 more things,” and that’s the hard
part. (P15)
There's just too many [metrics], and the administrative burden of capturing the data for many of them . . . is too much. So it
deters from true quality, and it deters from CCOs being able to focus on things that aren't quality metrics that could improve
quality even more because quality isn’t just about quality metrics. (P7)
Abbreviations: CCO, coordinated care organization; IT, information technology; OHA, Oregon Health Authority; P, participant.
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